IL6 and COVID-19: As described in several studies (21–23), we observed increased circulating levels of inflammatory cytokines such as IL-6, IP10, and GM-CSF in hospitalized patients compared with patients with mild COVID-19 (Figure 1) — in particular, if they had needed admission to ICU.